Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
International Journal of Molecular Sciences|February 11, 2023
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell CarcinomaSilvia Pomella, Matteo Cassandri, Ombretta Melaiu, et al.Cancers|August 14, 2025
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral KeratinocytesSilvia Pomella, Lucrezia D'Archivio, Matteo Cassandri, et al.Frontiers in Pharmacology|September 9, 2020
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue SarcomasMatteo Cassandri, Rossella Fioravanti, Silvia Pomella, et al.Muscles (Basel, Switzerland)|August 4, 2025
Heat Shock Proteins: Important Helpers for the Development, Maintenance and Regeneration of Skeletal MusclesSilvia Pomella, Matteo Cassandri, Francesco Antoniani, et al.Drug Discovery Today|October 29, 2025
Inhibition of bromodomain and extra-terminal motif (BET) proteins in pediatric sarcoma: A systematic review of in vitro and in vivo studiesErika Ferraro, Elisa Macrì, Clemens Zwergel, et al.International Journal of Molecular Sciences|February 25, 2023
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical StudiesOmbretta Melaiu, Gianluca Vanni, Ilaria Portarena, et al.Journal of Experimental & Clinical Cancer Research : CR|March 25, 2022
Epigenetic remodelling in human hepatocellular carcinomaMaria Rita Braghini, Oriana Lo Re, Ilaria Romito, et al.Nature Biotechnology|November 13, 2019
Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machineryAnna M Chiarella, Kyle V Butler, Berkley E Gryder, et al.Cells|November 27, 2021
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal RhabdomyosarcomaSimona Camero, Giulia Vitali, Paola Pontecorvi, et al.Frontiers in Oncology|October 17, 2022
Radioresistance in rhabdomyosarcomas: Much more than a question of doseSimona Camero, Matteo Cassandri, Silvia Pomella, et al.Pageof 5